Journey Strategic Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Buy |
743
+167
| +29% | +$87.6K | 0.01% | 351 |
|
|
2025
Q1 | $365K | Buy |
576
+99
| +21% | +$62.8K | 0.01% | 290 |
|
|
2024
Q4 | $340K | Sell |
477
-202
| -30% | -$144K | 0.01% | 303 |
|
|
2024
Q3 | $714K | Buy |
679
+97
| +17% | +$102K | 0.03% | 168 |
|
|
2024
Q2 | $612K | Buy |
582
+226
| +63% | +$238K | 0.03% | 142 |
|
|
2024
Q1 | $343K | Buy |
356
+49
| +16% | +$47.2K | 0.02% | 167 |
|
|
2023
Q4 | $270K | Buy |
+307
| New | +$270K | 0.01% | 156 |
|
|
2023
Q2 | – | Sell |
-334
| Closed | -$274K | – | 257 |
|
|
2023
Q1 | $274K | Buy |
+334
| New | +$274K | 0.03% | 170 |
|